HK8297A - DNA sequences from varicella-zoster virus vectors and hosts containing them the corresponding polypeptides and the compositions containing them - Google Patents

DNA sequences from varicella-zoster virus vectors and hosts containing them the corresponding polypeptides and the compositions containing them

Info

Publication number
HK8297A
HK8297A HK8297A HK8297A HK8297A HK 8297 A HK8297 A HK 8297A HK 8297 A HK8297 A HK 8297A HK 8297 A HK8297 A HK 8297A HK 8297 A HK8297 A HK 8297A
Authority
HK
Hong Kong
Prior art keywords
varicella
dna sequences
virus vectors
zoster virus
corresponding polypeptides
Prior art date
Application number
HK8297A
Other languages
English (en)
Inventor
Ronald W Ellis
Paul M Keller
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of HK8297A publication Critical patent/HK8297A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
HK8297A 1984-08-21 1997-01-16 DNA sequences from varicella-zoster virus vectors and hosts containing them the corresponding polypeptides and the compositions containing them HK8297A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/642,983 US4769239A (en) 1984-08-21 1984-08-21 Vaccine against varicella-zoster virus

Publications (1)

Publication Number Publication Date
HK8297A true HK8297A (en) 1997-01-24

Family

ID=24578863

Family Applications (1)

Application Number Title Priority Date Filing Date
HK8297A HK8297A (en) 1984-08-21 1997-01-16 DNA sequences from varicella-zoster virus vectors and hosts containing them the corresponding polypeptides and the compositions containing them

Country Status (6)

Country Link
US (1) US4769239A (xx)
EP (1) EP0192902B1 (xx)
JP (1) JP2597542B2 (xx)
CA (1) CA1272456A (xx)
DE (1) DE3585790D1 (xx)
HK (1) HK8297A (xx)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0260012A1 (en) * 1986-09-02 1988-03-16 Merck & Co. Inc. Promoter for expression of heterologous proteins in mammalian cells
US5169836A (en) * 1988-11-10 1992-12-08 Trustees Of The University Of Penna. Inhibitors of platelet binding
DE69017769T2 (de) * 1989-06-27 1995-07-13 Smithkline Beecham Biologicals S.A., Rixensart Verbindungen.
US6180369B1 (en) 1990-10-04 2001-01-30 Research Corporation Technologies, Inc. Varicella-zoster virus antigen
US5824319A (en) * 1990-10-04 1998-10-20 Research Corporation Technologies, Inc. Varicella-zoster virus antigen
EP0651789B2 (en) 1992-07-17 2009-05-20 Merck & Co. Inc. Method for preventing zoster and alleviating varicella related post-herpetic neuralgia
JPH09506777A (ja) * 1993-12-21 1997-07-08 メルク エンド カンパニー インコーポレーテッド 熱安定性の水痘帯状疱疹ウイルス
AU2361495A (en) * 1994-04-28 1995-11-29 Aviron A novel vzv gene, mutant vzv and immunogenic compositions
KR970006484A (ko) * 1995-07-27 1997-02-21 수두 바이러스의 당단백질을 대량발현시키는 동물세포주
GB0504436D0 (en) 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
GB201116248D0 (en) 2011-09-20 2011-11-02 Glaxosmithkline Biolog Sa Liposome production using isopropanol
US10232035B2 (en) 2012-09-14 2019-03-19 The Regents Of The University Of Colorado, A Body Corporate Conditionally replication deficient herpes virus and use thereof in vaccines
CA3003483C (en) 2015-11-06 2022-09-13 Adjuvance Technologies, Inc. Triterpene saponin analogues
WO2017177204A1 (en) * 2016-04-09 2017-10-12 La Jolla Institute For Allergy And Immunology Leveraging immune memory from common childhood vaccines to fight disease
BR112019011286A2 (pt) 2016-12-07 2019-10-15 Glaxosmithkline Biologicals Sa métodos para produzir uma composição de lipossoma, para preparar uma composição de vacina e para preparar um kit de vacina.
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
US20210187098A1 (en) 2017-04-28 2021-06-24 Glaxosmithkline Biologicals Sa Vaccination
BR112019025193A2 (pt) 2017-05-30 2020-06-23 Glaxosmithkline Biologicals S.A. Métodos de fabricação de um adjuvante lipossomal, de fabricação de um concentrado lipossomal, para a preparação de uma composição imunogênica com adjuvante e para a preparação de uma solução, adjuvante lipossomal, composição imunogênica com adjuvante, e, solução
JP2021504424A (ja) 2017-12-01 2021-02-15 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム サポニン精製
BR112021000965A2 (pt) 2018-08-07 2021-04-27 Glaxosmithkline Biologicals S.A. processos e vacinas
US20220339282A1 (en) 2018-11-29 2022-10-27 Glaxosmithkline Biologicals Sa Methods for manufacturing an adjuvant
EP3980044A1 (en) 2019-06-05 2022-04-13 GlaxoSmithKline Biologicals SA Saponin purification
CN112142829B (zh) * 2019-06-28 2022-02-22 怡道生物科技(苏州)有限公司 水痘-带状疱疹病毒gE蛋白突变体及其表达方法
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD147855A5 (de) * 1978-12-22 1981-04-22 Biogen Nv Verfahren zur erzeugung mindestens eines hbv-antigenwirkung aufweisenden polypeptids
EP0211756A1 (en) * 1985-08-01 1987-02-25 Merck & Co. Inc. Assay for varicella-zoster virus (VZV) antibodies

Also Published As

Publication number Publication date
JP2597542B2 (ja) 1997-04-09
EP0192902A3 (en) 1987-09-02
DE3585790D1 (de) 1992-05-07
JPS6181792A (ja) 1986-04-25
EP0192902A2 (en) 1986-09-03
EP0192902B1 (en) 1992-04-01
CA1272456A (en) 1990-08-07
US4769239A (en) 1988-09-06

Similar Documents

Publication Publication Date Title
HK8297A (en) DNA sequences from varicella-zoster virus vectors and hosts containing them the corresponding polypeptides and the compositions containing them
GB8424454D0 (en) Recombinant dna cloning vectors
GB2217718A (en) Recombinant avipox virus
AU8895882A (en) Recombinant dna
EP0263072A3 (en) Novel lymphokine related peptides
GB2160858B (en) Alumina-zirconia ceramic
GB8404378D0 (en) Dna sequence recombinant dna molecules
GB2068971B (en) Recombinant dna techniques
GB8823068D0 (en) Recombinant dna
EP0200425A3 (en) Recombinant dna expression vectors and dna compounds
GB8516281D0 (en) Peptides
EP0173557A3 (en) Peptides
ZA844857B (en) Novel peptides
NZ221374A (en) Recombinant interferon and compositions containing it
IL69851A0 (en) Novel dna and recombinant plasmid containing the same
IL81072A0 (en) Immunoamplifier polypeptide compositions
DE3560261D1 (en) Peptides
GB8400828D0 (en) Dna expression vectors
IL79880A0 (en) Recombinant virus
AU561372B2 (en) Streptokinase-coding recombinant vectors
GB8303383D0 (en) Sequences recombinant dna molecules
IL61952A0 (en) Recombinant dna techniques
ZA877417B (en) Novel lymphokine related peptides
GB8412158D0 (en) Recombinant dna derived antigens
GB8406569D0 (en) Recombinant dna molecules

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20040819